Skip to main content

Mayo Travis

Description

In 2017, the National Syndromic Surveillance Program (NSSP) continued to expand as a national scope data source with over 6,500 facilities registered on the BioSense Platform, including 4,000 active, 1,800 onboarding, and 700 planned or inactive facilities. 2,086 of the active facilities are Emergency Departments across 49 sites in 41 states. The growth of data available in NSSP has been driven by continued enhancements to tools and processes used by the NSSP Onboarding Team. These enhancements help to rapidly integrate new healthcare facilities and onboard new public health sites in support of American Hospital Association (AHA) Emergency Department (ED) representativeness goals. Furthermore, with these improvements to the onboarding process, including the Master Facility Table update process and automated data validation reporting, NSSP has broadened stakeholder participation in the onboarding process.

Objective:

This session will present the impacts of enhancements made to National Syndromic Surveillance Program (NSSP) BioSense Platform Onboarding in 2017 from the perspective of CDC and public health jurisdictions.

Submitted by elamb on
Description

One of the greatest hurdles for BioSense Onboarding is the process of validating data received to ensure it contains Data Elements of Interest (DEOI) needed for syndromic surveillance. Efforts to automate this process are critical to meet existing and future demands for facility onboarding requests as well as provide a foundation for data quality assurance efforts. By automating the validation process, BioSense hopes to:

1. Reduce costs associated with the iterative validation process.

2. Improve BioSense response times for assistance with onboarding.

3. Improve documentation to partners about requirements and communicate changes to DEOI.

4. Provide a better foundation for data quality initiatives.

Efforts to improve data validation are being developed in alignment with BioSense future initiatives and will apply to both BioSense, Essence and other BioSense program applications.

BioSense Onboarding identified critical success factors by participating in ISDS workgroup initiatives for Onboarding and Data Quality and soliciting feedback from key jurisdictional partners. These critical success factors include; improved documentation, access to raw data, and faster validation response time.

Objective

This session will inform the BioSense Community about data validation advancements implemented this past year as well as future plans to improve the BioSense validation process to achieve emergency department representativeness goals.

Submitted by teresa.hamby@d… on

NSSP Onboarding has historically been a very labor intensive and manual process that requires a great deal of guidance and time investment from NSSP Onboarding Team members.  In order to meet future demand, Jurisdictions will play a greater role in managing the onboarding of local facilities.

The objective for the next year is to begin creating resources that jurisdictions can use to help facilities perform self-guided onboarding.

To begin the process, the onboarding team is documenting the onboarding discussions and processes.